Author
Shi‐Ming Lin
Also Known As
Broeckel, U., Chen-Chun Lin, Chun-Yen Lin, Chun‐Yen Lin, Lin, S.-M., Marten, J., S M Lin, S. Lin, S. M. Lin, S.M. Lin
102
Publications
3.3K
Citations
26
H-Index
49
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 13 | 13 | 1.2K |
2 | Hepatology | 13 | 13 | 1.2K |
3 | Health Sciences | 4 | 4 | 154 |
4 | Emergency Medicine | 1 | 1 | 96 |
5 | Epidemiology | 1 | 1 | 32 |
Shi‐Ming Lin
×
45
Publications
2.9K
Citations
25
H-Index
| Year | Citations | |
|---|---|---|
1999 | 449 | |
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial Shukui Qin, Minshan Chen, Ann‐Lii Cheng, Surgical OncologyHepatologyMedicinePathologyHigh-risk Hepatocellular Carcinoma | 2023 | 415 |
2006 | 308 | |
2003 | 176 | |
1992 | 133 | |
2004 | 125 | |
2006 | 112 | |
2005 | 101 | |
2018 | 96 | |
1991 | 71 |
Page 1
Page 1